The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer

Table 2 Univariate and multivariate analyses of the prognostic factors on lymph node recurrence-free survival

Variable	5-year lymph node recurrence-free rate (%)	p value	HR (95 % CI)	p value
Age
≥70	96	0.972
<70	97
T stage
T3–T4	93	0.003	2.68 (0.91–7.90)	0.074
T1–T2	98
Gleason score
8–10	98	<0.001	5.99 (1.62–22.14)	0.007
≤7	90
PSA (ng/ml)
≥30	94	0.100	1.26 (0.33–4.82)	0.74
<30	97
RFLN (%)
>30	93	0.029	0.51 (0.10–2.60)	0.419
<30	98
ADT
Yes	96	0.732
No	96

ADT Androgen deprivation therapy, CI confidence interval, HR hazard ratio, RFLN Roach formula for the risk of pelvic lymph node metastasis

ISSN: 1477-7819